Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

101.96
Delayed Data
As of 3:59pm ET
 -5.25 / -4.90%
Today’s Change
55.00
Today|||52-Week Range
118.49
-5.98%
Year-to-Date
Gilead Sciences Inc.'s Worst Moves in 2016
Dec 06 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks to Buy on Sale
Nov 29 / MotleyFool.com - Paid Partner Content
Incyte Jakafi Positive in Pooled Analysis of Five-Year Data
Dec 05 / Zacks.com - Paid Partner Content
Intellipharmaceutics Submits NDA for Pain Treatment Rexista
Nov 28 / Zacks.com - Paid Partner Content
3 Reasons Why Incyte Corporation Stock Could Soar in 2017
Dec 03 / MotleyFool.com - Paid Partner Content
Read This Before You Buy Any Marijuana Stocks
Nov 26 / MotleyFool.com - Paid Partner Content
Agenus' INCAGN1876 in Phase I/II Study for Solid Tumors
Dec 01 / Zacks.com - Paid Partner Content
Merck (MRK) Announces 2.2% Increase in Quarterly Dividend
Nov 24 / Zacks.com - Paid Partner Content
3 Biotech Stocks to Buy in December
Dec 01 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close107.21
Today’s open106.53
Day’s range99.72 - 106.53
Volume1,946,962
Average volume (3 months)1,401,741
Market cap$20.2B
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+1,860.50%
Earnings growth (next 5 years)+170.10%
Revenue growth (last year)+47.36%
P/E ratio129.1
Price/Sales26.95
Price/Book116.92

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-2.80-3.58%
MYLMylan NV-1.36-3.79%
BAXBaxter International...+0.13+0.30%
ZTSZoetis Inc+1.04+2.07%
Data as of 4:02pm ET, 12/07/2016

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts


Search for Jobs